Search
Briacell Therapeutics Corp
BCTXAdd to Watchlist
3.950USD
+0.680+20.80%
Close 11-06 16:00（ET）
34.37MMarket Cap
LossP/E TTM
Today
+20.80%
5 Days
+29.93%
1 Month
+0.77%
6 Months
-5.73%
Year to Date
-44.44%
1 Year
-65.08%
Key Figures
3.340Open
4.080High
6.42KVolume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
3.270Prev. Close
3.300Low
23.75KTurnover
LossP/E Static
2.12P/B
0.00%Div Yield TTM
-139.50%ROA
13.09052wk High
0.08Volume Ratio
-26.31MNet Profit
8.70MShares
-14.4132EPS TTM
1.65Beta
-171.72%ROE
2.60052wk Low
30.03%Amplitude
--Gross Margin
34.37MMarket Cap
-1.06Reward/Risk
7.18%Risk Rate
More news coming soon, stay tuned...
Briacell Therapeutics Corp's Score
0.10vs previous score
Forecast--
Financial Health7.21
Technical5.34
Valuation Dimensions7.96
Institutional Confidence3.00
Risk Assessment--
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Briacell Therapeutics Corp Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.99/-2.74
Revenue / Forecast
--/0.00
Briacell Therapeutics Corp Profile
SectorBiotechnology & Medical Research
Ticker SymbolBCTX
Number of employees22
CountryCanada
Ownership
| Shareholders | Proportion |
|---|---|
| Iridian Asset Management LLC | 0.90% |
| Iroquois Capital Management, LLC | 0.79% |
| L5 Capital Inc. | 0.24% |
| UBS Financial Services, Inc. | 0.16% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 1.13% |
| Hedge Fund | 0.79% |
| Corporation | 0.24% |
| Investment Advisor | 0.17% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51882.500
+591.900 (+1.15%)
27240.900
+276.400 (+1.02%)
7445.400
+65.400 (+0.89%)
12797.000
-1.000 (-0.01%)
59200.000
+1058.000 (+1.82%)
6251.700
+111.100 (+1.81%)
86.732
-3.125 (-3.48%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4122.850
+57.180 (+1.41%)
FAQs
What is the current price of Briacell Therapeutics Corp (BCTX)?
The current price of Briacell Therapeutics Corp (BCTX) is 3.95.
What is the symbol of Briacell Therapeutics Corp?
The ticker symbol of Briacell Therapeutics Corp is BCTX.
What is the 52-week high of Briacell Therapeutics Corp?
The 52-week high of Briacell Therapeutics Corp is 13.09.
What is the 52-week low of Briacell Therapeutics Corp?
The 52-week low of Briacell Therapeutics Corp is 2.60.
What is the market capitalization of Briacell Therapeutics Corp?
The market capitalization of Briacell Therapeutics Corp is 34.37M.
Is Briacell Therapeutics Corp (BCTX) currently rated as Buy, Hold, or Sell?
According to analysts, Briacell Therapeutics Corp (BCTX) has an overall rating of Buy, with a price target of 40.00.
What is the Earnings Per Share (EPS TTM) of Briacell Therapeutics Corp (BCTX)?
The Earnings Per Share (EPS TTM) of Briacell Therapeutics Corp (BCTX) is -14.41.